These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15506410)

  • 1. [Ghrelin and bone metabolism].
    Komatsu Y; Nakao K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():384-7. PubMed ID: 15506410
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
    Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
    J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
    Svensson J; Ohlsson C; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Baylink D; Mohan S; Bengtsson BA
    J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin directly regulates bone formation.
    Fukushima N; Hanada R; Teranishi H; Fukue Y; Tachibana T; Ishikawa H; Takeda S; Takeuchi Y; Fukumoto S; Kangawa K; Nagata K; Kojima M
    J Bone Miner Res; 2005 May; 20(5):790-8. PubMed ID: 15824852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin: endocrine and non-endocrine actions.
    Broglio F; Arvat E; Benso A; Papotti M; Muccioli G; Deghenghi R; Ghigo E
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1219-27. PubMed ID: 12510973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stomach disease and ghrelin].
    Suzuki H; Ishii H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():399-405. PubMed ID: 15506414
    [No Abstract]   [Full Text] [Related]  

  • 9. Ghrelin and bone mass in postmenopausal hypertensive women.
    Pérez-Castrillón JL; Justo I; Sanz A; San Miguel A; Mazón MA; Abad L; Vega G; Dueñas A
    Ann Nutr Metab; 2007; 51(3):223-7. PubMed ID: 17587793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin and bone.
    van der Velde M; Delhanty P; van der Eerden B; van der Lely AJ; van Leeuwen J
    Vitam Horm; 2008; 77():239-58. PubMed ID: 17983859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)].
    Masaki H; Miki T
    Clin Calcium; 2006 Nov; 16(11):1823-32. PubMed ID: 17079849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoporosis in patients with diabetes mellitus].
    Yamauchi M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():526-30. PubMed ID: 18161160
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemical markers for bone metabolism--overview].
    Nakatsuka K; Nishizawa Y
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():220-7. PubMed ID: 11979911
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ghrelin in the treatment of cardiovascular disease].
    Nagaya N; Kangawa K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():430-4. PubMed ID: 15506421
    [No Abstract]   [Full Text] [Related]  

  • 15. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
    Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
    Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart.
    Frascarelli S; Ghelardoni S; Ronca-Testoni S; Zucchi R
    Basic Res Cardiol; 2003 Nov; 98(6):401-5. PubMed ID: 14556085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of ghrelin in fetuses and neonates].
    Murakami N; Nakahara K; Kangawa K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():392-5. PubMed ID: 15506412
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of vitamin K may be a good choice for microgravity-induced bone disorder.
    Sugiyama T; Kawai S
    J Bone Miner Res; 2001 Apr; 16(4):794-5. PubMed ID: 11316009
    [No Abstract]   [Full Text] [Related]  

  • 19. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G; Izzo G; La Montagna G; Bellastella A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastrectomy].
    Ohtsuru A; Nagata Y; Enjoji A; Kanematsu T; Yamashita S
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():406-9. PubMed ID: 15506415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.